- Avivagen (TSXV:VIV) has announced its first purchase order in Mexico
- The company is currently finalising sales agreements with Mexican feed miller Industrias Melder
- The purchase order is for 350 kilograms of OxC-beta Livestock, and 1,000 bags of Vivamune
- Avivagen and Industrias Melder are also collaborating to conduct confirmatory testing of OxC-beta Livestock on different species
- Avivagen Inc (VIV) remains unchanged, and is currently trading at $0.51 per share
Life sciences company Avivagen (TSXV:VIV) has announced its first purchase orders of OxC-beta Livestock and Vivamune in Mexico.
The company is currently finalising sales agreements with Mexican feed miller, Industrias Melder, S.A. De C.V.
Industrias Melder was established in 1949, and is located in Guadalajara, Mexico.
The feed milling company sells commercial livestock feed for dairy, poultry, and swine producers. It also owns and operates a chain of retail pet stores.
Industrias Melder’s purchase order includes 350 kilograms of Avivagen’s alternative antibiotic compound, OxC-beta Livestock. Avivagen has previously used it to reduce sub-clinical mastitis in dairy cows.
The purchase order also asks for 1,000 bags of Vivamune, a canine immune supplement. Industrias Melder will sell the product through Super Pet, the retail pet store chain which it owns.
Avivagen CEO, Kym Anthony, was excited to announce the company’s first purchase orders of OxC-beta Livestock and Vivamune in Mexico.
“Our first purchase orders in Mexico pave the way for continued distribution and acceptance of our technology in major feed markets worldwide.
“With annual feed sales of more than 36 million tonnes (compared with 18.2 million for the Philippines, 20.2 million for Thailand, and 21.6 million for Canada), Mexico represents a fast-growing and important market for OxC-beta Livestock.
“We are confident that the demand for OxC-beta Livestock in Mexico and throughout North America will rapidly expand,” Kym predicted.
In addition to the purchase order, Avivagen is also working with Industrias Melder to conduct confirmatory testing of OxC-beta Livestock in different species.
This collaboration followed Avivagen’s recent presentation at a technical seminar series in Guadalajara. The seminars, hosted by the Mexican Association of Food Producers (AMEPA), were attended by numerous feed and livestock producers.
Avivagen Inc (VIV) remains unchanged, and is currently trading at $0.51 per share, as of 9:56am EST.